Chylomicron: Difference between revisions
Jump to navigation
Jump to search
Rim Halaby (talk | contribs) No edit summary |
Rim Halaby (talk | contribs) No edit summary |
||
| Line 3: | Line 3: | ||
{{CMG}}; {{AE}} {{AN}}; {{RT}} | {{CMG}}; {{AE}} {{AN}}; {{RT}} | ||
== [Chylomicron overview|Overview]] == | == [[Chylomicron overview|Overview]] == | ||
== [Chylomicron historical perspective|Historical Perspective]] == | == [[Chylomicron historical perspective|Historical Perspective]] == | ||
== [Chylomicron classification|Classification]] == | == [[Chylomicron classification|Classification]] == | ||
== [Chylomicron biochemistry|Biochemistry]] == | == [[Chylomicron biochemistry|Biochemistry]] == | ||
== [Chylomicron physiology|Physiology]] == | == [[Chylomicron physiology|Physiology]] == | ||
== Clinical Correlation== | == Clinical Correlation== | ||
| Line 21: | Line 21: | ||
== Treatment == | == Treatment == | ||
[Chylomicron medical therapy|Medical Therapy]] | [Chylomicron primary prevention|Primary Prevention]] | [Chylomicron secondary prevention|Secondary Prevention]] | [Chylomicron landmark trials|Landmark Trials]] | [Chylomicron future or investigational therapies|Future or Investigational Therapies]] | [[Chylomicron medical therapy|Medical Therapy]] | [[Chylomicron primary prevention|Primary Prevention]] | [[Chylomicron secondary prevention|Secondary Prevention]] | [[Chylomicron landmark trials|Landmark Trials]] | [[Chylomicron future or investigational therapies|Future or Investigational Therapies]] | ||
{{Lipoproteins}} | {{Lipoproteins}} | ||
Revision as of 17:04, 12 September 2013
|
High Density Lipoprotein Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Clinical Trials |
|
Case Studies |
|
Chylomicron On the Web |
|
American Roentgen Ray Society Images of Chylomicron |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Aarti Narayan, M.B.B.S [2]; Raviteja Guddeti, M.B.B.S. [3]
Overview
Historical Perspective
Classification
Biochemistry
Physiology
Clinical Correlation
High Chylomicron
Epidemiology and Demographics | Pathophysiology | Causes | Diseases | Prognosis and Complications
Low Chylomicron
Epidemiology and Demographics | Pathophysiology | Causes | Diseases | Prognosis and Complications
Treatment
Medical Therapy | Primary Prevention | Secondary Prevention | Landmark Trials | Future or Investigational Therapies